Peter Reaven

Director, Diabetes Research Program, Phoenix VA Health Care System · University of Arizona College of Medicine - Phoenix

Credentials: · · ·

History

Use of Continuous Glucose Monitoring and Long-Term Diabetes Outcomes Within the Veteran Affairs Health Care System
Department of Veterans Affairs · I01
Contact PI · Phoenix Va Health Care System
2023–2027
Apolipoprotein-C Proteoforms in Dyslipidemia and Cardiovascular Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.3M · Arizona State University-Tempe Campus
2018–2023
A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications
National Heart, Lung, and Blood Institute · R21
PI · $250K · University of California Los Angeles
2020–2023
Role of Methionine Sulfoxide and Advanced Glycation Endproducts in Cardiovascular and Renal Complications of Type 2 Diabetes
National Heart, Lung, and Blood Institute · R21
PI · $223.3K · Arizona Veterans Research and Education Foundation
2019–2022

Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
Principal investigator · Unknown · Phase 4
Phoenix VA Health Care System
2014–2019
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Principal investigator · Completed · Phase 4
Phoenix VA Health Care System
2013–2023
Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
Principal investigator · Completed · Phase 4
Phoenix VA Health Care System
2013–2019
Dietary Lipid Induced Insulin Resistance
Principal investigator · Unknown
Phoenix VA Health Care System
2012–2020